Cargando…
Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma—A Review of the Literature
Pancreatic cancer (PC) is considered to be the seventh most common cause of cancer-related deaths. The number of deaths caused by PC is estimated to increase in the future. An early diagnosis of PC is crucial for improving treatment outcomes. The most common histopathological subtype of PC is pancre...
Autores principales: | Wnuk, Jakub, Strzelczyk, Joanna Katarzyna, Gisterek, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049684/ https://www.ncbi.nlm.nih.gov/pubmed/36982210 http://dx.doi.org/10.3390/ijms24065113 |
Ejemplares similares
-
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018) -
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
por: Makler, Amy, et al.
Publicado: (2022) -
Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas
por: Domagała-Haduch, Małgorzata, et al.
Publicado: (2023) -
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017) -
Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
por: Supadmanaba, I Gede Putu, et al.
Publicado: (2021)